The document discusses solutions for enabling development of the hemp bioactives industry in Canada by creating integrated supply chains using intellectual property. It proposes a system of networked generic supply chains licensed by a control tower operating system. This would allow various sectors such as food, nutraceuticals, pharmaceuticals, licensed marijuana producers and dispensaries to commercialize hemp derivatives within regulations. The intellectual property could provide licensing opportunities to rapidly expand the hemp bioactives industry in Canada and generate economic benefits.
Lifespan Pharma Inc-Extend Lifespan Naturally-business plan pitchMorris Johnson
lifespan.pharma.inc@gmail.com is pitching this new patented healthspan optimization aid till may 30 to accredited investors in Saskatchewan 701-240-9411, 306-447-4944
box 33, beaubier, saskatchewan, S0C-0H0
Canada .. any comments??
Creating and infrastructure to enable the commercialization of CBD and hemp bioactives within existing regulatory frameworks requires an innovative solution
National Program for organic Production NPOP certification in India. NPOP is APEDA Monitored certification program in India. APEDA monitors the implementation of National Program for Organic Production in India
The purpose of this webinar is to give an overview as well as in-depth detail and links to important food regulations on ORGANIC CERTIFICATION in China, US, and EU. This webinar explains what “organic” is and is not, organic laws in China, US, and EU, how to get certified, and what “mutual recognition” for organic means when an agreement is in place between countries. Similarities and differences among China, US, and EU organic food schemes and certification requirements are also highlighted.
National Program for Organic Certification in India. NPOP is indian organic certification standard, It monitors the use of India Organic Logo by certified operations. STOCERT provides certification services in India
Lifespan Pharma Inc-Extend Lifespan Naturally-business plan pitchMorris Johnson
lifespan.pharma.inc@gmail.com is pitching this new patented healthspan optimization aid till may 30 to accredited investors in Saskatchewan 701-240-9411, 306-447-4944
box 33, beaubier, saskatchewan, S0C-0H0
Canada .. any comments??
Creating and infrastructure to enable the commercialization of CBD and hemp bioactives within existing regulatory frameworks requires an innovative solution
National Program for organic Production NPOP certification in India. NPOP is APEDA Monitored certification program in India. APEDA monitors the implementation of National Program for Organic Production in India
The purpose of this webinar is to give an overview as well as in-depth detail and links to important food regulations on ORGANIC CERTIFICATION in China, US, and EU. This webinar explains what “organic” is and is not, organic laws in China, US, and EU, how to get certified, and what “mutual recognition” for organic means when an agreement is in place between countries. Similarities and differences among China, US, and EU organic food schemes and certification requirements are also highlighted.
National Program for Organic Certification in India. NPOP is indian organic certification standard, It monitors the use of India Organic Logo by certified operations. STOCERT provides certification services in India
Gives information, importance and objectives of various food laws and standards of India. helps to understand indian food standards better. Functions of various food laws helps to learn to purchase food products as a consumer.
The Hemp Biz is a family of media brands including Hemp Biz Journal, Hemp Biz News and Hemp Biz Summit. The Hemp Biz Journal is the definitive source for market sizes and high-level analysis of business trends in one of the fastest emerging markets in the United States. The company provides data, market intelligence and strategic information to businesses and investors all for the price of a few hours of a consultant's time.
Keynote address at the Hemp Biz Summit at NoCo Hemp Conference. Presentation includes my "tour de force" of hemp around the planet the last four months and highlights key industry data driving innovation, job creation and investments.
Presentation given at the Science of Industrial Hemp Conference exploring primary driver for the hemp industry across global sustainability business trends, including key players and lots of data.
Presentation at Pax Christi Catholic Church describing how I came to be in the Order of Malta, the Order's mission to serve the sick and the poor, and places I've visited around the world to celebrate and understand the Order's historical significance and works of charity as the world's oldest medical mission.
Learn about hemp investments and the early stage verticals where companies and products are emerging in the United States hemp industry, with special focus on the Colorado hemp economy.
Gives information, importance and objectives of various food laws and standards of India. helps to understand indian food standards better. Functions of various food laws helps to learn to purchase food products as a consumer.
The Hemp Biz is a family of media brands including Hemp Biz Journal, Hemp Biz News and Hemp Biz Summit. The Hemp Biz Journal is the definitive source for market sizes and high-level analysis of business trends in one of the fastest emerging markets in the United States. The company provides data, market intelligence and strategic information to businesses and investors all for the price of a few hours of a consultant's time.
Keynote address at the Hemp Biz Summit at NoCo Hemp Conference. Presentation includes my "tour de force" of hemp around the planet the last four months and highlights key industry data driving innovation, job creation and investments.
Presentation given at the Science of Industrial Hemp Conference exploring primary driver for the hemp industry across global sustainability business trends, including key players and lots of data.
Presentation at Pax Christi Catholic Church describing how I came to be in the Order of Malta, the Order's mission to serve the sick and the poor, and places I've visited around the world to celebrate and understand the Order's historical significance and works of charity as the world's oldest medical mission.
Learn about hemp investments and the early stage verticals where companies and products are emerging in the United States hemp industry, with special focus on the Colorado hemp economy.
Learn how to prepare your startup for impact investment from friends and family, angels or institutional investors---learn about social return (SROI), environmental return (EROI) and financial return (ROI). Presented by mentors Sean Murphy and Chris Baker in Zimbabwe as part of the U.S. State Department Professional Fellows Program.
A presentation on industrial hemp tracking the history of hemp and some of the most innovative companies in this emerging industry in the the United States.
Learn about hemp investments and the early stage investment verticals and categories where companies and products are emerging in the United States hemp industry.
In 2017, Colombia put in force a regulatory framework on safe and informed access to medical and scientific use of cannabis and its derivatives. The regulation regulates the cultivation, sale, derivatives, and use of cannabis seeds for medicinal and scientific purposes.
Unit 2. Regulatory requirements for setting herbal drug industry:
Content: Global marketing management.
Indian and International patent law as applicable herbal drugs and natural products.
Export - Import (EXIM) policy, TRIPS.
Quality assurance in herbal/natural drug products.
Concepts of TQM, GMP, GLP, ISO-9000.
Chicago Cannabis Company in collaboration with Equity and Transformation hosted a Cannabis Infusion Workshop at the Quarry Event Center in South Shore. The workshop covered the essentials of the infuser license, requirements for applicants, the basics of infusion, and cannabis 101.
How can CBD still be applied in food products after the most recent change in the Novel Food Catalogue, according to which CDB foods are, in principle, Novel Foods?
New 2024 CBD Products Manufacturing Investor Pitch Deck TemplateCannaBusinessPlans
We offer a '70% ready to go' professional CBD Products Manufacturing Investor Pitch Deck Template for PowerPoint. The template is completely open and editable, and all you have to do is add your company information. https://hempcbdbusinessplans.com/product/investor-pitch-deck-template-hemp-cbd-manufacturing-business/
It includes information about regulatory bodies, role of drug Regulatory professional, countries with their regulatory bodies, intellectual property rights, terminologies related to DRA, drug approval process, event regarding lack of Drug regulatory affairs
Tristan and nixon birthday-canterpene hemp birthday cardMorris Johnson
Birthday card from Grandpa Morris Folke Johnson and Denise Rollheiser Johnson to grandsons Tristan and Nixon Brodsky, Kelowna - 04 August at Saskatoon, Saskatchewan
Canterpene Bio Derivatives (C.B.D.) products and supply chainMorris Johnson
overview of Canterpene Bio Derivatives (C.B.D.) supply chain and products lines.
Patented industrial hemp production methods transform CBD from a drug and pharmaceutical product to a food and nutraceutical substance
Molecular hydrogen biomed-applications-888Morris Johnson
molecular hydrogen is a very simple yet never yet commercialized regenerative medicine agent.
My patent seeks to create the economic infrastructure to support a broad range of applications based upon a solid base of evidence for efficacy as an anti-aging tool.
Humanity+2010 june13-d1 s2-ver2-transcripted-notedMorris Johnson
morris johnson hplussummit presentation
with the transcript converted to slides..the official unabridged version of HACCP as a lifespan and healthspan comprehensive integrated management system...several other hplus speakers including ronald bailey, maria kovanolenko, aubrey de grey, melanie swan, andrew hessel, robert tercek
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ocular injury ppt Upendra pal optometrist upums saifai etawah
The Canadian Industrial Hemp Bioproducts Industry
1. The Hemp Bioactives Conundrum - A Simplified Solution
- Nutraceutical potential has been limited due to perception that hemp
bioactives may be regulated as Schedule F drugs
- Generic nature of the science discourages proprietary pharmaceutical
commercialization within pharma parameters due to generic economics
- The solution is to create a robust set of networked, interdependent generic
hemp based supply chains with mass commercialization of affordable products
- The solution is Innovation via Intellectual Property that can
be broadly licensed as opposed to simple silos with isolated
regulations which discourage innovation and commercialization of
all silos in an interactive, integrated manner
- The solution is a control tower operating system that licenses compatible
applications and capitalizes on the economies of scale
- Canadian Patent 2,921,553 describes the methods to enable all components
- Multiple sector-networked supply chains maximize the value
- Bioactive applications are embodied as formulations in products
- Developers are the hemp bioactives industry innovators
2. The Hemp Bioactives Conundrum – Enabling Development
- Government control has focused on tracking THC, a component hemp is bred
to have a very low level of while ignoring the bioactive entourage
- Other cannabinoids and terpenes exist in biomass; regulations stifle
commercialization of these compounds due to lack of clarity
- Intellectual property innovated to fill this vacuum via utilization of a loophole in regulation
which allows biomass to be converted to derivatives as a “bin run” raw material
- Once derivatives are created only the THC limits are currently tracked
- Terpenes, and cannabinoids, are listed in several food, NHP and pharma schedules so
derivatives are targeted to appropriate applications which match uses to regulations
- Intellectual Property controls and tracks supply more effectively than
centralized regulatory policing and facilitates regulatory compliance
- Pharmaceutical, nutraceutical, medical marijuana licensed producers, unlicensed
dispensaries and food processors all have applications utilizing derivatives as feedstock
- Intellectual property can be licensed to allow governments to collect excise taxes on any
specific hemp bioactive (eg CBD) in compliance with future laws and regulations
- Royalties allow the IP owners to place strategic investments to fill the gaps
in areas they see as bottlenecks for hemp bioactives industry expansion
- Patents can provide generic licensing opportunities to ramp up the industry
3. The Hemp Bioactives Conundrum – Supply Chains
- Farmers, as growers, are paid a premium to manage crops to maximize bioactive content
- Patented harvest method enables on farm production of derivatives as a part of harvest
- Mechanical separations, solvent extractions, fractionations create
supply chains for custom-compounding raw materials
- Secondary derivatives include dietary fibre, protein powder, oilseed granules, full bioactive
nutraceutical flour, residual bioactive food flours, oils with various bioactive profiles,
nutraceutical bioactive-rich protein powder and utility flour concentrates
- Tertiary derivatives include edibles with varied bioactive profiles with food,
nutraceutical and medical applications, dermal preparations in cosmetics
and cosmeceuticals, highly refined bioactives concentrates with various
profiles for food, flavor, aroma, supplement and medical formulations.
- A supply-chain patent tracks the bioactives disposition when it gathers one royalty
at the farm-gate and a second royalty at the retailer (checksum of inventory).
- Contracting of farm supply as part of Intellectual Property licensing guarantees
supply chain players a continuing supply of product profile-specific ingredients
4. The Hemp Bioactives Conundrum – The Food Sector
- Current products include
protein powder, edible oils and oilseed powders and granules
- Future products include
edibles with hemp bioactive content
cooking flours and oils with bioactive content
- Food categories include
margarines, soda pop, candies, beverages,
baked goods, soups, cakes and pastries to name a few
Regulations have and will continue to set the allowable bioactive
parameters of the finished consumer goods which are formulated
with bioactive concentrates and hemp derivatives
5. The Hemp Bioactives Conundrum – The Nutraceutical Sector
- Concentrated derivatives and bioactives formulations in powder and oil
and tinctures can be used as starting materials for single and
compounded formulations including:
- dry capsules and tablets
- gel capsules
- dermal formulations
- flavorings
- compounded multi-component herbal products
6. The Hemp Bioactives Conundrum – The Licenced Producer Sector
- Persons with prescriptions for medical marijuana require marijuana formulations
high in hemp bioactives other than THC, especially
- cannabidiol, minor cannabinoids including caryophyllene and caryophyllene oxide
- bioactive terpenes including myrcene, linalool, alpha pinene, humulene, limonene
- licensed producers can authorize and contract processing by GMP, site-licensed
pharma and nutraceutical manufacturers to create products of pharmaceutical
quality suitable not only for DTC but also pharmacy dispensed products,
liquor and other specialty vendors and export to USA and countries where
CBD is an over-the-counter compound.
- licensed producers can purchase generic hemp derivatives to include as
base material for their cannabis products
- licensed producers can focus on THC, and outsource CBD, so as to
maximize the productivity of indoor production
capacity and capital management
7. The Hemp Bioactives Conundrum – The Pharmaceutical Sector
- Pharmaceutical companies globally researching pharmaceutical
formulations need a reliable source of raws or contract manufactured
ingredients to proceed to commercial products
- In countries where CBD is not regulated as a drug, such as Switzerland,
pharma companies desire to receive hemp bioactives and
derivatives of all sorts.
- In the USA where CBD is widely marketed, it is likely a market
for products formulated by GMP, Site Licensed Canadian facilities
would meet with no objections from Federal Regulators
8. The Hemp Bioactives Conundrum – The Dispensary Sector
- Although dispensaries may or may not be properly licensed or regulated
so are considered illegally operating, they embody the provision within
the Natural Health Product regulations that exempts businesses who
manufacture custom compounded formulations for customers on the orders
of an alternative health practitioner with or without dispensation
by a licensed compounding pharmacist
- Dispensaries also carry edibles and novel formulations from which
to use to formulate custom compounded products
- Dispensaries are within the hemp industry, the equivalent of the farmers market
in the commercial food industry, so are an evolving sector. It is in the
best interests of regulators to use collaboration instead of confrontation
in assisting and working with the dispensary sector as it matures into
a long term player that fits a niche of its own creation
- The entire industry has watched the dispensaries and learned what works,
and what does not, from their experiences
9. The Hemp Bioactives Conundrum – The Black Market Sector
- Currently all sorts of businesses procure amounts of hemp from farmers
and sell everything from dispensary products to highly manufactured
high concentration crystal high CBD for domestic or export sale, as well
as converting CBD from hemp using acid, time and temperature into THC
products, without any regard for law or regulation
- Over the last 3 years, several CHTA-member hemp farmers and processors have
begun to supply the dispensary and black market with substantial quantities of
hemp bioactives destined for the medical marijuana and recreational markets.
A hemp-industry-driven authorization to supply emerging legal supply chains would
remove the economic incentive for diverting bioactives to unapproved applications
more effectively than the perceived punishments which currently are not
curbing these transactions.
- Patent holders working together with Health Canada and CHTA would
then back-track these supply chains and to bring this production into
legally-approved channels engaging in regulated and approved transactions.
10. The Hemp Bioactives Conundrum – Summary : 12 September 2016
The combination of Health Canada MMPR, OCS, Hemp, NHP and CFIA food safety
agencies complement all the categories and types of players likely
to want to commercialize hemp bioactives in Canada.
CIPO-derived patents and IP complement the regulatory platform.
“There is a globally emerging healthspan and lifespan extension market which most
of the players can target-market to. This developing market can grow what is a
2,000 acre biomass acreage in 2016 to about 20,000 acres in 2018 and 200,000
acre by 2022. The economc benefit to both public and private sectors is obviously
significant. It is critical that Canada be a first mover in this industry.
2 cents per milligram of CBD in multiple formulations, if delivered at a consolidated
daily dose of 100 mg a day as a dietary delivered supplement for 25 million people,
would consume 16,000 acres and generate a gross market value of 2 billion CAD annually.
Canada, with a default public medicare system, has the moral hazard that health-supporting
ingredients which are not fully commercialized in a timely fashion cost medicare and the
taxpayer for avoidable Crisis Management and Palliative Care resource allocations. “
Morris Johnson holds title to the aforementioned IP and is the author of this presentation.
Morris Johnson / Lifespan Pharma Inc.
24-1035 Boychuk Drive, Saskatoon, Sask., S7H-5B2
1-306-716-7822
Lifespan.pharma.inc@gmail.com